Welcome to our dedicated page for BIOLARGO news (Ticker: BLGO), a resource for investors and traders seeking the latest updates and insights on BIOLARGO stock.
BioLargo, Inc. (BLGO) focuses on delivering sustainable technology-based products to address critical issues in water, food, agriculture, healthcare, and energy sectors. The company's subsidiary, BioLargo Water, Inc., is known for its advanced oxidation systems, including the AOS filter, designed to efficiently eliminate toxic contaminants in water. BioLargo has received the Technology Star Award for its breakthrough innovation in the oil industry and recognized as a technology innovation leader in the water treatment market. Additionally, the company owns a 50% interest in the Isan System, which has been honored as a top 50 water company for the 21st century.
BioLargo, Inc. (OTCQB:BLGO) announced that its Aqueous Electrostatic Concentrator (AEC) technology can treat water to meet the EPA's proposed drinking water standards for PFAS, specifically PFOA and PFOS. The Biden-Harris administration proposed national drinking water regulations on March 14, 2023, targeting six PFAS chemicals with strict limits, including four parts per trillion for PFOA and PFOS. The AEC has demonstrated effectiveness in reducing PFAS levels in multiple studies. This regulatory change may increase demand for BioLargo's solutions as municipalities seek to comply with the new standards, which prioritize reducing contamination in drinking water.
BioLargo, Inc. (OTCQB:BLGO) announced the appointment of Nicholas Valeriani and Linda Park to its subsidiary Clyra Medical Technologies' board of directors. Valeriani brings 34 years of experience from Johnson & Johnson and holds multiple board positions, while Park has over 20 years of corporate governance experience with Edwards Lifesciences and Western Digital. The board expects their expertise will accelerate the commercialization of Clyra's innovative medical products, including BioClynse, an FDA 510(k)-cleared wound irrigation product. The leadership change aims to bolster strategic growth and operational efficiency for the company.
BioLargo, Inc. (OTCQB:BLGO) will feature CEO Dennis Calvert in a virtual fireside chat on January 25, 2023, at 12 PM ET via the Paltalk platform. This event is part of ClearThink IR's initiative, aimed at providing investors insights into emerging micro-cap companies. Attendees can engage directly in a Q&A session following the discussion. BioLargo focuses on developing sustainable cleantech and environmental engineering solutions addressing critical issues such as PFAS contamination and air quality improvement. For details on joining the event, visit here.
BioLargo (OTCQB:BLGO) reported a preliminary revenue of over $5.75 million for 2022, reflecting a remarkable 125% growth compared to 2021. CEO Dennis P. Calvert stated this success stems from a broad portfolio of sustainable technologies. The company anticipates continued growth in 2023, driven by its PFAS removal water treatment systems and other engineering projects. BioLargo is also expanding its network of channel partners in the U.S. and Canada, enhancing its market presence in the environmental technology sector.
BioLargo, Inc. (OTCQB:BLGO) announced the retail launch of its pet odor remover, Pooph, at over 600 Walmart locations across the United States. This marks the first step in a planned national distribution. According to Ikigai Marketing Works, the product's sales have exceeded expectations, with a strong marketing strategy highlighting its effective odor elimination. BioLargo continues to support Ikigai in expanding brand awareness. The company is recognized for its innovative cleantech solutions and extensive patent portfolio.
BioLargo, Inc. (OTCQB:BLGO) reported significant growth in its Q3 2022 results, achieving a 111% increase in revenue, totaling $1.5 million. For the nine months ending September 30, 2022, revenue reached $3.79 million, a 117% increase from 2021. The company highlighted successful partnerships, notably in pet odor control, and advancing its PFAS treatment technology. Noteworthy is ONM Environmental's growth, with revenues of $1.2 million this quarter. The company anticipates continued growth and expansion in the environmental engineering sector.
BioLargo, Inc. (OTCQB:BLGO) announced an investor webcast and conference call on November 16, 2022, at 2:00 PM Pacific/5:00 PM Eastern. The session will cover financial results for the three and nine months ending September 30, 2022, recent milestones, and a Q&A. Attendees can access the live broadcast via this link. BioLargo specializes in sustainable technologies and environmental engineering, holding numerous patents and partnerships aimed at addressing environmental challenges.
BioLargo, Inc. (OTCQB:BLGO) announced key results from its municipal wastewater treatment pilot at a conference in Halifax, Nova Scotia. The company showcased its patented Advanced Oxidation System (AOS), demonstrating a significant improvement in removing pharmaceutical micropollutants from wastewater. Over 18 months of testing at a facility near Montreal, the AOS increased removal efficiency to 84%-100%, compared to less effective current technologies. The company aims to position the AOS as a leader in the expanding market for micropollutant treatment as regulatory concerns grow worldwide.
BioLargo, Inc. (OTCQB: BLGO) announced the addition of two new board members, Linda Park and Christina Bray, enhancing its leadership team. Park, an executive with over 20 years of experience in corporate governance, previously worked with Edward Lifesciences and Western Digital. Bray, a finance specialist and CEO of Bluedot Energies, is recognized for her expertise in renewable energy technologies and capital projects. The company aims to leverage their experience to advance its cleantech vision. Retiring board members have transitioned to advisory positions.
BioLargo, Inc. (OTCQB:BLGO) reported a new quarterly revenue record of approximately $1.5 million for Q3 2022, up 13% from Q2 2022 and 111% year-over-year. The company’s growth was driven primarily by sales of its POOPH pet odor product. CEO Dennis P. Calvert emphasized ongoing expansion efforts and upcoming launches, including a PFAS removal project and consumer product rollouts. The full financial results are expected to be filed with the SEC by November 14, 2022, along with a planned investor webcast.
FAQ
What is the current stock price of BIOLARGO (BLGO)?
What is the market cap of BIOLARGO (BLGO)?
What does BioLargo, Inc. focus on?
What is BioLargo Water, Inc. known for?
What awards has BioLargo received?
What is Isan System?
